Core-Shell Fibrous Scaffolds for Controlled Drug Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current scaffold technologies face challenges in controllably releasing proteins or drugs, particularly in achieving a sustained and sequential delivery of growth factors for tissue regeneration, with existing methods often resulting in initial burst effects and inadequate long-term release profiles.
Innovation Solution
A method for preparing core-shell structured fibrous scaffolds by adding calcium phosphate cement and a protein or drug to an alginate solution, then hardening the compositions using a concentric nozzle in a calcium ion solution, allowing for controlled release profiles by varying the composition of the core and shell parts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If growth factors are adsorbed on the scaffold surface, then the scaffold can deliver therapeutic molecules, but substantial initial burst effects occur due to weak electrostatic interactions
Solution Approach 1:
The scaffold is divided into core and shell regions with different compositions. The core contains growth factors embedded in the matrix, while the shell provides a controlled release barrier. This segmentation allows the growth factors to be protected within the core and released in a controlled manner through the shell, eliminating the burst effect while maintaining therapeutic delivery capability.
Solution Approach 2:
Different regions of the scaffold are given different local properties: the core region has high growth factor concentration and specific composition, while the shell region has different porosity and composition to control release. This local quality differentiation enables sustained release from the core through the shell, preventing burst effects while ensuring reliable therapeutic delivery.
2Duration of action of stationary object
If growth factors are incorporated within the scaffold microstructure, then sustained release is achieved, but control over release timing and sequence is limited
Solution Approach 1:
The scaffold is segmented into core and shell with distinct compositions and release characteristics. The core provides sustained release reservoir, while the shell can be engineered with specific porosity and thickness to control release timing. This segmentation enables both long-duration release and adaptable release profiles by adjusting shell properties.
Solution Approach 2:
The scaffold uses composite materials with different properties in core and shell regions. The core may contain growth factors in a specific matrix, while the shell uses different materials with controlled degradation or porosity characteristics. This composite structure enables both sustained release duration and versatile release profile control by selecting appropriate materials for each region.
3Adaptability or versatility
If dual/multiple growth factors are delivered sequentially, then synergistic bone formation is achieved, but the scaffold structure and delivery mechanism become more complex
Solution Approach 1:
The scaffold is segmented into core and shell regions that can each contain different growth factors. By placing different growth factors in different regions (e.g., VEGF in core, BMP in shell), sequential delivery is achieved through the natural diffusion gradient from core to shell. This segmentation approach enables multi-factor delivery without requiring complex multi-layer structures, as the core-shell architecture itself provides the sequential release mechanism.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the development of scaffolds that can controllably release proteins or drugs, achieving sustained and sequential delivery of growth factors, enhancing tissue regeneration by optimizing release profiles and mechanical properties.
Implementation Method 1
hardening the compositions using a concentric nozzle in a calcium ion solution
Data Source
AI summary
The present invention relates to a preparation method for core-shell structured fibrous scaffolds, and more specifically to preparing a core part composition and a shell part composition that each have different constitutions by adding calcium phosphate cement and a protein, drug of combination thereof to alginate solution, and then inserting the above core part composition and shell part composition to internal and external nozzle of concentric nozzle respectively to inject into calcium ion aqueous solution and thereby hardening them, thus preparing core-shell structured rapidly setting Alg/α-TCP scaffolds capable of controllably releasing a protein or drug.